Homocysteine, folate deprivation and Alzheimer neuropathology

Journal of Alzheimer's Disease

Volumn 4, Issue 4, 2002, Pages 261-267

  Shea, Thomas B ^a   Lyons Weiler, James ^a   Rogers, Eugene ^a  

^a UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); AMYLOID BETA PROTEIN; CYSTATHIONINE; CYSTATHIONINE BETA SYNTHASE; DNA; FOLIC ACID; GLUTAMIC ACID; HOMOCYSTEINE; METHIONINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; FOLIC ACID DEFICIENCY; GENETIC POLYMORPHISM; HUMAN; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROTOXICITY; NUTRITIONAL DEFICIENCY; PRIORITY JOURNAL; REVIEW;

EID: 0036669551     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2002-4401     Document Type: Review

References (85)

1. R.H. Allen, S.P. Stabler and J. Lindenbaum, Relevance of vitamins, homocysteine and other metabolites in neuropsychiatric disorders, Eur J Pediatr 157(2) (1998), S122-S126.
2. L.I. Al-Gazali, R. Padmanabhan, S. Melnyk, P. Yi, I.P. Pogribny, M. Pogribna, M. Bakir, Z.A. Hamid, Y. Abdulrazzaq, A. Dawodu and S.J. James, Abnormal folate metabolism and genetic polymorphism of the folate pathway in a child with Down syndrome and neural tube defect, Am J Med Genet 103 (2001), 128-132.
3. V.R. Arrula, P.M. von Zuben, L.C. Chaiparini, J.M. Annichino-Bizzachi and F.F. Costa, The mutation Ala677-Val in the methylene tetrahydrofolate reductase gene: A risk factor for arterial disease and venous thrombosis, Thrombo Haemost 77 (1997), 818-821.
4. R.V. Banerjee and R.G. Matthews, Cobalamin-dependent methionine synthase, FASEB 4 (1990), 1450-1459.
5. T. Bottiglieri, P. Godfrey, T. Flynn, M.W. Carney, B.K. Toone and E.H. Reynolds, Cerebrospinal fluid S-adenosylmethionine in depression and dementia: Effects of treatment with parenteral and oral S-adenosylmethionine, J Neurol Neurosurg Psychiatry 53 (1990), 1096-1098.
6. T. Bottiglieri, K. Hyland and E.H. Reynolds, The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders, Drugs 48 (Aug 1994), 137-152.
7. L.D. Botto and Q. Yang, 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: A HuGE review, Am J Epidemiol 151 (2000), 862-867.
8. M. Candito, P. Bedoucha, D. Jambou, A. Appert-Flory, F. Fisher, F. Parrot-Roulaud, J. Bayle, E. Van Obberghen and M. Chatel, Cerebral vascular complication of hyperhomocysteinemia. Controlling thromboembolic complications with folates, Presse Med 26 (1997), 1289-1291.
9. G.L. Cantoni, The centrality of S-adenosylhomocysteine in the regulation of the biological utilization of S-adenosylmethionine, in: Biological Methylation and Drug Design: Experimental and Clinical Roles of SAM, C. Borchardt and P.M. Ueland, eds, Humana Press Inc., Clifton, 1986, pp. 227-237.
10. R. Clarke, A.D. Smith, K.A. Jobst, H. Refsum, L. Sutton and P.M. Ueland, Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease, Arch 55 (1998), 1449-1455.
11. G.P. Davey, S. Peuchen and J.B. Clark, Energy thresholds in brain mitochondria. Potential involvement in neurodegeneration, J Biol Chem 273 (1998), 12753-12757.
12. S. Dhitavant, E. Rogers and T.B. Shea, Differential efficacy of lipophilic and cytosolic antioxidants on generation of reactive oxygen species by amyloid-beta, J Alz Dis 3 (2001), 525-529.
13. R. Djurhuus, A.M. Svardal and P.M. Ueland, Differential effects on growth, homocysteine, and related compounds of two inhibitors of S-adenosylhomocysteine catabolism, 3-deazaadenosine, and 3-deazaaristeromycin, in C3H/10T1/2 cells, Cancer Res 49 (1989), 324-330.
14. S.N. Doshi, I.F.W. McDowell, S.J. Moat, D. Lang, R.G. Newcombe, M.B. Kredan, M.J. Lewis and J. Goodfello, Folate improves endothelial function in coronary artery disease; An effect mediated by reduction of intracellular superoxide, Arterioscler Thromb Vasc Biol 21 (2001), 1196-1202.
15. W. Duan, B. Ladenheim, R.G. Cutler, I.I. Kruman, J.L. Cadet and M.P. Mattson, Dietary folate defeciency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease, J Neurochem 80 (2002), 101-110.
16. E.M. Ebly, J.P. Schaefer, N.R. Campbell and D.B. Hogan, Folate status, vascular disease and cognition in elderly Canadians, Age Ageing 27 (1998), 485-491.
17. D. Fekkes, T.J. van der Cammen, C.P. van Loon, C. Verschoor, F. van Harskamp, I. de Koning, W.J. Schudel and L. Pepplinkhuizen, Abnormal amino acid metabolism in patients with early stage Alzheimer's dementia, J Neural Transm 105 (1998), 287-294.
18. J.D. Finkelstein, The metabolism of homocysteine: Pathways and regulation, Eur J Pediatr 157(2) (1998), S40-S44.
19. T. Fiskerstrand, P.M. Ueland and H. Refsum, Folate depletion induced by methotrexate affects methionine synthase activity and its susceptibility to inactivation by nitrous oxide, J Pharmacol Exp Ther 282 (1997), 1305-1311.
20. P. Frosst, H.J. Blom, R. Milos, P. Goyette, C.A. Sheppard, R.G. Matthews, G.J. Boers, M. den Heijer, L.A. Kluijtmans and L.P. van den Heuvel, A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase, Nat Genet 10 (1995), 111-113.
21. C.G. Gottfries, W. Lehmann and B. Reglan, Early diagnosis of cognitive impairment in the elderly with the focus on Alzheimer's disease, J Neural Transm 105 (1998), 773-786.
22. W.B. Grant, Dietary links to Alzheimer's disease: 1999 Update, J Alz Dis 1 (1999), 197-201.
23. G.E. Gray, Nutrition and dementia, J Am Diet Assoc 89 (1989), 1795-1802.
24. T. Gulesserian, R. Seidl, R. Hardmeier, N. Cairns and G. Lubec, Superoxide dismutase SOD1, encoded on chromosome 21, but not SOD2 is overexpressed in brains of patients with Down syndrome, J Investig Med 49 (2001), 41-46.
25. L. Hassing, A. Wahlin, B. Winblad and L. Backman, Further evidence on the effects of vitamin B12 and folate levels on episodic memory functioning: A population-based study of healthy very old adults, Biol Psychiatry 45 (1999), 1472-1480.
26. S.M. Henning, M.E. Swendseid, B.T. Ivandic and F. Liao, Vitamins C, E and A and heme oxygenase in rats fed methyl/folate-deficient diets, Free Radic Biol Med 23 (1997), 936-942.
27. P. Ho, D. Ashline, S. Dhivat, D. Ortiz, E. Rogers and T.B. Shea, Homocysteine potentiates Amyloid beta neurotoxicity: Role of oxidative stress, J Neurochem 78 (2001), 249-253.
28. P. Ho, D. Ashline, S. Dhitavat, D. Ortiz, S.C. Collins, E. Rogers and T.B. Shea, Folate deprivation induces neurodegeneration: Roles of oxidative stress and increased homocysteine, Mol Biol Cell 12 (2001), 120a.
29. R.F. Huang, Y.C. Hsu, H.L. Lin and F.L. Yang, Folate depletion and elevated plasma homocysteine promote oxidative stress in rat livers, J Nutr 131 (2001), 33-88.
30. B. Hultberg, A. Andersson, P. Masson, M. Larson and A. Tunek, Plasma homocysteine and thiol compound fractions after oral administration of N-acetylcysteine, Scand J Clin Lab Invest 54 (1994), 417-422.
31. K. Hyland, I. Smith, T. Bottiglieri, J. Perry, U. Wendel, P.T. Clayton and J.V. Leonard, Demyelination and decreased S-adenosylmethionine in 5,10-methylenetetrahydrofolate reductase deficiency, Neurology 38 (1988), 459-462.
32. R.C. Iannello, P.J. Crack, J.B. de Haan and I. Kola, Oxidative stress and neural dysfunction in Down syndrome, J Neural Transm 57 (1999), 257-267.
33. S.J. James, M. Pogribna, I.P. Pogribny, S. Melnyk, R.J. Hine, J.B. Gibson, P. Yi, D.L. Tafoya, D.H. Swenson, V.L. Wilson and D.W. Gaylor, Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome, Am J Clin Nutr 70 (1999), 495-501.
34. R. Joshi, S. Sdhikare, B.S. Patro, S. Chattopadhyay and T. Mukherjee, Free radical scavenging behavior of folic acid: Evidence for possible antioxidant activity, Free Rad Biol Med 30 (2001), 1390-1399.
35. E. Joosten, E. Lesaffre, R. Riezler, V. Ghekiere, L. Dereymaeker, W. Pelemans and E. Dejaeger, Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer's disease? J Gerontol A Biol Sci Med Sci 52 (1997), M76-M79.
36. G.G. Klee, Colbalamin and folate evaluation: Measurement of methylmalonic acid and homocysteine vs. vitamin B12 and folate, Clin Chem 46 (2000), 1277-1283.
37. J.I. Kourie, Mechanisms of amyloid beta protein-induced modification in ion transport systems: implications for neurodegenerative diseases, Cell Mol Neurobiol 21 (2001), 173-213.
38. D. Knopman and M. Patterson, An open-label, 24-week pilot study of the methyl donor betaine in Alzheimer disease patients, Alzheimer Dis Assoc Disord 15 (2001), 162-165.
39. I.I. Kruman, C. Culmsee, S. Chan, Y. Kruman, Z. Guo, L. Penix and M.P. Mattson, Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity, J Neurosci 20 (2000), 6920-6926.
40. I.I. Kruman, T.S. Kumaravel, A. Lohani, W.A. Pedersen, G. Roy, R.G. Cutler, K. Yuri, N. Norman Haughey, J. Lee, M. Michele Evans and M.P. Mattson, Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease, J Neurosci 22 (2002), 1752-1762.
41. M. Lehmann, C.G. Gottfries and B. Regland, Identification of cognitive impairment in the elderly: homocysteine is an early marker, Dement Geriatr Cogn Disord 10 (1999), 12-20.
42. J. Lejeune, Biochemical investigations and trisomy 21, Ann Genet 22 (1979), 67-75.
43. S.A. Lipton, W.-K. Kim, Y.-B. Choi, S. Kumar, D.M. D'Emilia, P.V. Rayudu, D.R. Arnelle and J.S. Stamler, Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor, Proc Natl Acad Sci USA 94 (1997), 5923-5928.
44. I.T. Lott and E. Head, Down syndrome and Alzheimer's disease: a link between development and aging, Ment Retard Dev Disabil Res Rev 7 (2001), 172-178.
45. M.D. Lucock, I.G. Daskalakis, J. Wild, A. Anderson, C.J. Schorah, M.E.J. Lean and M.I. Levene, The influence of dietary folate and methionine on the metabolic disposition of endotoxic homocysteine, Biochem Mol Med 59 (1996), 104-111.
46. J. Ma, M.J. Stampfer, B. Christensen, E. Giovannucci, D. Hunter, J. Chen, W.C. Willett, J. Selhub, C.H. Hennekens, R. Gravel and R. Rozen, A Polymorphism of the Methionine Synthase Gene: Association with Plasma Folate, Vitamin B12, Homocys(e)ine, and Colorectal Cancer Risk, 1999.
47. I. McDowell, Alzheimer's disease: Insights from epidemiology, Aging 13 (2000), 143-162.
48. M.P. Mckeever, A.M. Molloy and D.G. Weir et al., Betainehomocysteine methyltransferase organ distribution in man, pig and rat and subcellular distribution in the rat, Clin Sci 81 (1991), 551-556.
49. J.W. Miller, Homocysteine and Alzheimer's disease, Nutr Rev 57 (1999), 126-129.
50. J.W. Miller, Homocysteine, Alzheimer's disease and cognitive function, Nutrition 16 (2000), 675-677.
51. S. Miranda, C. Opazo, L.F. Larrondo, F.J. Munoz, F. Ruiz, F. Leighton and H.C. Inestrosa, The role of oxidative stress in the toxicity induced by amyloid beta peptide in Alzheimer's disease, Prog Neurobiol 62 (2000), 633-648.
52. L.D. Morrison, D.D. Smith and S.J. Kish, Brain S-adenosylmethionine levels are severely decreased in Alzheimer's disease, J Neurochem 67 (1996), 1328-1331.
53. G. Munch, R. Schinzel, C. Loske, A. Wong, N. Durany, J.J. Li, H. Vlassara, M.A. Smith, G. Perry and P. Riederer, Alzheimer's disease - Synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts, J Neural Transm 105 (1998), 439-461.
54. S.H. Mudd and G.L. Cantoni, Biological transmethylation methyl-group neogenesis and other one carbon metabolic reactions dependent upon tetrahydrofolic acid, in: Comprehensive biochemistry, (Vol. 15), M. Florkin and E.H. Stot, eds, Elsevier, Amsterdam, 1964, pp. 147.
55. S.H. Mudd, F. Skovby, H.L. Levy, K.D. Pettigrew, B. Wilcken, R.E. Pyeritz, G. Andria, G.H. Boers, I.L. Bromberg and R. Cerone et al., The natural history of homocystinuria due to cystathionine beta-synthase deficiency, Am J Hum Genet 37 (1985), 1-31.
56. P.E. Newman, Could diet be used to reduce the risk of Alzheimer's disease? Med Hypotheses 50 (1988), 335-337.
57. H. Nilsson-Ehle, Age-related changes in cobalamin (vitamin B12) handling. Implications for therapy, Drugs Aging 12 (1998), 277-292.
58. F. Nourhashemi, S. Gillette-Guyonnet, S. Andrieu, A. Ghisolfi, P.J. Ousset, H. Grandjean, A. Grand, J. Pous, B. Vellas and J.L. Albarede, Alzheimer disease: Protective factors, Am J Clin Nutr 71 (2000), 643S-649S.
59. V.B. O'Leary, A. Parle-McDermott, A.M. Molloy, P.N. Kirke, Z. Johnson, M. Conley, J.M. Scott and J.L. Mills, MTRR and MTHFR polymorphism: Link to Down syndrome? Am J Med Genet 107 (2002), 151-155.
60. G. Oliveri, G. Baysang, F. Meier, F. Müller-Spahn, H.B. Stähelin, Brockhaus and C.H. Brack, N-acetyl-L-cysteine protects SHSY5Y neuroblastoma cells from oxidative stress and cell cytotoxicity: Effects on β-amyloid secretion and tau phosphorylation, J Neurochem 76 (2001), 224-233.
61. R.B. Parsons, R.H. Waring, D.B. Ramsden and A.C. Williams, In vitro effect of the cysteine metabolites homocysteic acid, homocysteine and cysteic acid upon human neuronal cell lines, Neurotoxicology 19 (1998), 599-603.
62. C. Pereira, M.S. Santos and C. Oliveira, Involvement of oxidative stress on the impairment of energy metabolism induced by Abeta peptides on PC12 cells: Protection by antioxidants, Neurobiol Dis 6 (1999), 209-219.
63. C.B. Pocemich, A.L. Cardin, C.L. Racine, C.M. Lauderback and D.A. Butterfield, Glutathione elevation and its protective role in acrolein-induced protein damage in synaptosomal membranes: Relevance to brain lipid peroxidation in neurodegenerative disease, Neurochem Int 39 (2001), 141-149.
64. M. Pogribna, S. Melnyk, I. Pogribny, A. Chango, P. Yi and S.J. James, Homocysteine metabolism in children with Down syndrome: In vitro modulation, Am J Hum Genet 69 (2001), 88-95.
65. L.F. Prescott, J.W. Donovan, D.R. Jarvie and A.T. Proudfoot, The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage, Eur J Clin Pharmacol 37 (1989), 501-506.
66. B. Regland and C.G. Gottfries, Slowed synthesis of DNA and methionine is a pathogenetic mechanism common to dementia in Down's syndrome, AIDS and Alzheimer's disease? Med Hypotheses 38 (1992), 11-19.
67. M.J. Renvall, A.A. Spindler, J.W. Ramsdell and M. Paskvan, Nutritional status of free-living Alzheimer's patients, Am J Med Sci 298 (1989), 20-27.
68. E. Ronge and B. Kjellman, Long term treatment with betaine in methylenetetrahydrofolate reductase deficiency, Arch Dis Child 74 (1996), 239-241.
69. D.S. Rosenblatt, Folate and homocysteine metabolism and gene polymorphisms in the etiology of Down syndrome, Am J Clin Nutr 70 (1999), 429-430.
70. S. Seshadri, A. Beiser, J. Selhub, P. Jacques, I. Rosenberg, R. D'agostino, P.W. Wilson and P.A. Wolf, Plasma homocysteine as a risk factor for dementia and Alzheimer's disease, New Eng J Med 346 (2002), 476-483.
71. J. Selhub and J.W. Miller, The pathogenesis of homocysteinemia: Interruption of the coordinate regulation by S-adenosylmethionine of theremethylation and transsulfuration of homocysteine, Am J Clin Nutr 55(1) (Jan 1992), 131-138.
72. J.M. Serot, D. Christman, T. Dubost, M.C. Bene and G.C. Faure, CSF-folate levels are decreased in late-onset AD patients, J Neural Transm 108 (2001), 93-99.
73. V.L. Smith-Swintosky and M.P. Mattson, Glutamate, betaamyloid precursor proteins, and calcium mediated neurofibrillary degeneration, J Neural Transm 44 (1994), 29-45.
74. D.A. Snowdon, C.L. Tully, C.D. Smith, D. Riley and W. Markesbery, Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: Findings from the Nun Study, Am J Clin Nutr 71 (2000), 993-998.
75. M.A. Smith, G.J. Petot and G. Perry, Diet and oxidative stres: A novel synthesis of epidemiological data on Alzheimer's disease, J Alz Dis 1 (1999), 203-206.
76. L.L. Stern, J.B. Mason, J. Selhub and S.W. Choi, Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene, Cancer Epidemiol Biomarkers Prev 9 (2000), 849-853.
77. S.L. Sunden, M.S. Renduchintala, E.I. Park, S.D. Miklasz and T.A. Garrow, Betaine-homocysteine methyltransferase expression in porcine and human tissues and chromosomal localization of the human gene, Arch Biochem Biophys 345 (1997), 171-174.
78. R. Surtees, J. Leonard and S. Austin, Association of demyelination with deficiency of cerebrospinal-fluid S-adenosylmethionine in inbom errors of methyl-transfer pathway, Lancet 338 (1991), 1550-1554.
79. R. Surtees, A. Bowron and J. Leonard, Cerebrospinal fluid and plasma total homocysteine and related metabolites in children with cystathionine beta-synthase deficiency: The effect of treatment, Pediatr Res 42 (1997), 577-582.
80. R.J. Trissler, Folic acid and Down syndrome, J Am Diet Assoc 100 (2000), 159.
81. G.R. Upchurch, G.N. Welch, A.J. Fabian, J.E. Freedman, J.L. Johnson, J.F. Keaney and J. Loscalzo, Homocysteine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase, J Biol Chem 272 (1997), 17012-17017.
82. J.H. Walter, J.E. Wraith, F.J. White, C. Bridge and J. Till, Stategies for the treatment of cystathionine beta-synthase deficiency: The experience of the Willink Biochemical Genetics Unit over the past 30 years, Eur J Pediatr 157(2) (1998), S71-S76.
83. H.-X. Wang, A. Wahlin, H. Basun, J. Fastom, B. Winblad and L. Fratiglioni, Vitamin B12 and folate in relation to the development of Alzheimer's disease, Neurol 56 (2001), 1188-1194.
84. D. Watkins and D.S. Rosenblatt, Functional methionine synthase deficiency (cb1E and cb1G): clinical and biochemical heterogeneity, Am J Med Genet 34 (1989), 427-434.
85. A.R. White, X. Huang, M.F. Jobling, C.H. Barrow, K. Beyreuther, C.L. Masters, A.I. Bush and R. Cappai, Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary cultures: Possible risk factors in the Alzheimer's-type neurodegenerative pathways, J Neurochem 76 (2001), 1509-1520.